Philipp Wiggermann

New frontiers in liver resection for hepatocellular carcinoma

Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis

Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations

Hepatocellular carcinoma

A global view of hepatocellular carcinoma: trends, risk, prevention and management

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease

High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy

Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives

Advances in functional and molecular MRI technologies in chronic liver diseases

Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma: natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging

Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients

Hepatocellular carcinoma

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

AASLD guidelines for the treatment of hepatocellular carcinoma

Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series

Multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease severity

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Pancreatic cancer: why is it so hard to treat?

Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T ₁ -weighted MRI

Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions

Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients

Factors Associated with Short-Term Local Recurrence of Liver Cancer after Percutaneous Ablation Using Irreversible Electroporation: A Prospective Single-Center Study

Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry

Volume-assisted estimation of liver function based on Gd-EOB-DTPA–enhanced MR relaxometry

Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation

Percutaneous Irreversible Electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors

Irreversible Electroporation of Malignant Hepatic Tumors - Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up

MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score

Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis

Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience

Electrochemotherapy as a New Modality in Interventional Oncology: A Review

Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)